Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.85K Hold
80
– – ﹤0.01% 228
2026
Q2
$4.19K Hold
80
– – ﹤0.01% 215
2026
Q1
$4.42K Hold
80
– – ﹤0.01% 200
2025
Q4
$3.92K Hold
80
– – ﹤0.01% 206

Other funds holding GSK

Walsh & Associates's GSK Position: Q3 2026 in Review

Walsh & Associates held its GSK (GSK) position steady in Q3 2026 at 80 shares worth $3.85K. The position accounts for ﹤0.01% of the portfolio, ranked #228.

Walsh & Associates first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. The position peaked at $4.42K in Q1 2026. 992 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Walsh & Associates held 80 shares of GSK worth $3.85K as of Q3 2026.
  • Walsh & Associates left its GSK share count unchanged in Q3 2026.
  • GSK made up ﹤0.01% of Walsh & Associates's portfolio in Q3 2026, its #228 holding.
  • Walsh & Associates first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
  • Walsh & Associates's GSK position peaked at $4.42K in Q1 2026.
  • 992 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.